Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Hosted on Acast. See acast.com/privacy for more information.
| Episode | Date |
|---|---|
|
Understanding the mechanism of BTK inhibitors
|
Apr 29, 2026 |
|
Strategic Sequencing in Relapsed Refractory Multiple Myeloma
|
Jan 13, 2026 |
|
Prise en charge des patients atteints de LLC doublement exposée et réfractaire.
|
Nov 18, 2025 |
|
Addressing the management of patients with double exposed and refractory CLL
|
Nov 18, 2025 |
|
CAR T-cell Therapy in 2025: Evidence, Safety, and Patient Selection
|
Sep 24, 2025 |
|
Practical considerations in the management of early rrMM in the Canadian context
|
Jan 06, 2025 |
|
The role of selinexor in early rrMM and sequencing in 2024.
|
Jun 26, 2024 |